Showing 1 - 10 of 3,087
explains the theory of new drug approval and uses historical scientific and regulatory materials to illustrate that the …
Persistent link: https://www.econbiz.de/10014121943
This paper examines the impact of the local opioid epidemic on corporate innovation. Using a large sample of U.S. public firms from 2003 to 2017, we find that firms located in counties with higher death rates caused by opioid overdoses are significantly less innovative as measured by their...
Persistent link: https://www.econbiz.de/10014236623
Persistent link: https://www.econbiz.de/10001477869
Persistent link: https://www.econbiz.de/10009738384
In this paper we discuss how cooperation and trust among entrepreneurs can be challenged when they are dealing with venture creation in the context of radical innovation. Entomology-based foods are considered as one of the most promising innovation in the food sector. However they impose radical...
Persistent link: https://www.econbiz.de/10010511316
Persistent link: https://www.econbiz.de/10012178383
Persistent link: https://www.econbiz.de/10011619297
Persistent link: https://www.econbiz.de/10014451221
This study investigates the effect of individual health conditions on individual innovation output, utilizing the staggered passage of recreational marijuana policies as an exogenous shock. Employing a large and current sample of U.S. inventors from 2010 to 2018, our study identifies a...
Persistent link: https://www.econbiz.de/10014344367
Persistent link: https://www.econbiz.de/10011523939